annual total assets:
$792.34M+$326.71M(+70.17%)Summary
- As of today (July 4, 2025), CLDX annual total assets is $792.34 million, with the most recent change of +$326.71 million (+70.17%) on December 31, 2024.
- During the last 3 years, CLDX annual total assets has risen by +$347.69 million (+78.19%).
- CLDX annual total assets is now at all-time high.
Performance
CLDX Total assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total assets:
$739.47M-$52.87M(-6.67%)Summary
- As of today (July 4, 2025), CLDX quarterly total assets is $739.47 million, with the most recent change of -$52.87 million (-6.67%) on March 31, 2025.
- Over the past year, CLDX quarterly total assets has dropped by -$129.38 million (-14.89%).
- CLDX quarterly total assets is now -14.89% below its all-time high of $868.85 million, reached on March 31, 2024.
Performance
CLDX quarterly total assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total assets Formula
Total Assets = Current Assets + Non-Current Assets
CLDX Total assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +70.2% | -14.9% |
| 3 y3 years | +78.2% | +74.4% |
| 5 y5 years | +544.5% | +557.3% |
CLDX Total assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +124.6% | -14.9% | +163.9% |
| 5 y | 5-year | at high | +544.5% | -14.9% | +261.5% |
| alltime | all time | at high | >+9999.0% | -14.9% | >+9999.0% |
CLDX Total assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $739.47M(-6.7%) |
| Dec 2024 | $792.34M(+70.2%) | $792.34M(-3.7%) |
| Sep 2024 | - | $823.18M(-2.6%) |
| Jun 2024 | - | $845.59M(-2.7%) |
| Mar 2024 | - | $868.85M(+86.6%) |
| Dec 2023 | $465.63M(+32.0%) | $465.63M(+66.1%) |
| Sep 2023 | - | $280.26M(-6.4%) |
| Jun 2023 | - | $299.31M(-7.8%) |
| Mar 2023 | - | $324.52M(-8.0%) |
| Dec 2022 | $352.74M(-20.7%) | $352.74M(-4.5%) |
| Sep 2022 | - | $369.23M(-8.4%) |
| Jun 2022 | - | $402.96M(-5.0%) |
| Mar 2022 | - | $424.04M(-4.6%) |
| Dec 2021 | $444.65M(+88.5%) | $444.65M(-3.4%) |
| Sep 2021 | - | $460.20M(+125.0%) |
| Jun 2021 | - | $204.55M(-6.6%) |
| Mar 2021 | - | $219.06M(-7.1%) |
| Dec 2020 | $235.84M(+91.8%) | $235.84M(-7.8%) |
| Sep 2020 | - | $255.77M(-2.2%) |
| Jun 2020 | - | $261.40M(+132.3%) |
| Mar 2020 | - | $112.50M(-8.5%) |
| Dec 2019 | $122.93M(-21.1%) | $122.93M(-6.8%) |
| Sep 2019 | - | $131.84M(-7.3%) |
| Jun 2019 | - | $142.24M(-3.6%) |
| Mar 2019 | - | $147.58M(-5.3%) |
| Dec 2018 | $155.81M(-50.6%) | $155.81M(-7.4%) |
| Sep 2018 | - | $168.29M(-5.7%) |
| Jun 2018 | - | $178.38M(-6.8%) |
| Mar 2018 | - | $191.38M(-39.4%) |
| Dec 2017 | $315.62M(-17.7%) | $315.62M(-1.2%) |
| Sep 2017 | - | $319.42M(-7.7%) |
| Jun 2017 | - | $346.07M(-3.9%) |
| Mar 2017 | - | $360.05M(-6.1%) |
| Dec 2016 | $383.36M(+13.6%) | $383.36M(+52.2%) |
| Sep 2016 | - | $251.95M(-7.1%) |
| Jun 2016 | - | $271.21M(-10.2%) |
| Mar 2016 | - | $301.93M(-10.6%) |
| Dec 2015 | $337.58M(+36.1%) | $337.58M(-4.3%) |
| Sep 2015 | - | $352.63M(-8.0%) |
| Jun 2015 | - | $383.22M(-6.0%) |
| Mar 2015 | - | $407.70M(+64.4%) |
| Dec 2014 | $248.01M(-28.5%) | $248.01M(-8.7%) |
| Sep 2014 | - | $271.67M(-8.7%) |
| Jun 2014 | - | $297.59M(-6.6%) |
| Mar 2014 | - | $318.70M(-8.2%) |
| Dec 2013 | $347.10M(+176.5%) | $347.10M(+91.8%) |
| Sep 2013 | - | $180.96M(-7.8%) |
| Jun 2013 | - | $196.23M(-12.5%) |
| Mar 2013 | - | $224.37M(+78.7%) |
| Dec 2012 | $125.54M(+28.1%) | $125.54M(+4.8%) |
| Sep 2012 | - | $119.84M(-1.9%) |
| Jun 2012 | - | $122.13M(-10.7%) |
| Mar 2012 | - | $136.74M(+39.5%) |
| Dec 2011 | $97.99M(-10.9%) | $97.99M(-9.6%) |
| Sep 2011 | - | $108.45M(-8.5%) |
| Jun 2011 | - | $118.48M(+28.2%) |
| Mar 2011 | - | $92.40M(-16.0%) |
| Dec 2010 | $109.94M(-21.7%) | $109.94M(-1.7%) |
| Sep 2010 | - | $111.81M(-8.0%) |
| Jun 2010 | - | $121.57M(-8.2%) |
| Mar 2010 | - | $132.44M(-5.6%) |
| Dec 2009 | $140.36M(+101.1%) | $140.36M(+191.8%) |
| Sep 2009 | - | $48.10M(-11.6%) |
| Jun 2009 | - | $54.41M(-14.3%) |
| Mar 2009 | - | $63.48M(-9.0%) |
| Dec 2008 | $69.79M(+644.5%) | $69.79M(-11.9%) |
| Sep 2008 | - | $79.19M(-8.3%) |
| Jun 2008 | - | $86.34M(+111.6%) |
| Mar 2008 | - | $40.80M(+335.3%) |
| Dec 2007 | $9.37M(-84.8%) | $9.37M(-78.4%) |
| Sep 2007 | - | $43.40M(-11.8%) |
| Jun 2007 | - | $49.21M(-9.4%) |
| Mar 2007 | - | $54.34M(-11.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $61.48M(+68.7%) | $61.48M(-4.0%) |
| Sep 2006 | - | $64.05M(-6.6%) |
| Jun 2006 | - | $68.55M(-6.5%) |
| Mar 2006 | - | $73.31M(+101.1%) |
| Dec 2005 | $36.45M(-20.4%) | $36.45M(-9.0%) |
| Sep 2005 | - | $40.06M(-9.9%) |
| Jun 2005 | - | $44.48M(+10.7%) |
| Mar 2005 | - | $40.17M(-12.3%) |
| Dec 2004 | $45.80M(+46.3%) | $45.80M(-0.7%) |
| Sep 2004 | - | $46.13M(-5.7%) |
| Jun 2004 | - | $48.90M(-6.6%) |
| Mar 2004 | - | $52.33M(+67.2%) |
| Dec 2003 | $31.31M(-11.1%) | $31.31M(-11.0%) |
| Sep 2003 | - | $35.17M(+22.2%) |
| Jun 2003 | - | $28.78M(-10.1%) |
| Mar 2003 | - | $32.02M(-9.1%) |
| Dec 2002 | $35.23M(-34.1%) | $35.23M(-8.9%) |
| Sep 2002 | - | $38.69M(-8.5%) |
| Jun 2002 | - | $42.26M(-11.4%) |
| Mar 2002 | - | $47.73M(-10.8%) |
| Dec 2001 | $53.48M(-15.9%) | $53.48M(+14.8%) |
| Sep 2001 | - | $46.58M(-12.7%) |
| Jun 2001 | - | $53.34M(-8.1%) |
| Mar 2001 | - | $58.05M(-8.7%) |
| Dec 2000 | $63.56M(+219.7%) | $63.56M(+18.0%) |
| Sep 2000 | - | $53.85M(+150.3%) |
| Jun 2000 | - | $21.52M(-12.4%) |
| Mar 2000 | - | $24.56M(+23.5%) |
| Dec 1999 | $19.88M(-12.2%) | $19.88M(-15.0%) |
| Sep 1999 | - | $23.40M(+41.8%) |
| Jun 1999 | - | $16.50M(-16.2%) |
| Mar 1999 | - | $19.70M(-13.0%) |
| Dec 1998 | $22.65M(+131.1%) | $22.65M(-9.8%) |
| Sep 1998 | - | $25.10M(+156.1%) |
| Jun 1998 | - | $9.80M(-15.5%) |
| Mar 1998 | - | $11.60M(+18.4%) |
| Dec 1997 | $9.80M(-43.0%) | $9.80M(-14.8%) |
| Sep 1997 | - | $11.50M(-14.2%) |
| Jun 1997 | - | $13.40M(-10.7%) |
| Mar 1997 | - | $15.00M(-12.8%) |
| Dec 1996 | $17.20M(-7.0%) | $17.20M(-10.9%) |
| Sep 1996 | - | $19.30M(+65.0%) |
| Jun 1996 | - | $11.70M(-27.3%) |
| Mar 1996 | - | $16.10M(-13.0%) |
| Dec 1995 | $18.50M(-10.6%) | $18.50M(+58.1%) |
| Sep 1995 | - | $11.70M(-21.5%) |
| Jun 1995 | - | $14.90M(-17.2%) |
| Mar 1995 | - | $18.00M(-13.0%) |
| Dec 1994 | $20.70M(-37.5%) | $20.70M(-18.2%) |
| Sep 1994 | - | $25.30M(-9.0%) |
| Jun 1994 | - | $27.80M(-9.4%) |
| Mar 1994 | - | $30.70M(-7.3%) |
| Dec 1993 | $33.10M(+47.8%) | $33.10M(+92.4%) |
| Sep 1993 | - | $17.20M(-10.4%) |
| Jun 1993 | - | $19.20M(-8.6%) |
| Mar 1993 | - | $21.00M(-13.9%) |
| Dec 1992 | $22.40M(-17.0%) | - |
| Oct 1992 | - | $24.40M(-5.8%) |
| Jul 1992 | - | $25.90M(-4.1%) |
| Apr 1992 | - | $27.00M(-3.6%) |
| Apr 1992 | $27.00M(+104.5%) | - |
| Jan 1992 | - | $28.00M(-1.4%) |
| Oct 1991 | - | $28.40M(-4.7%) |
| Jul 1991 | - | $29.80M(+125.8%) |
| Apr 1991 | $13.20M(-15.4%) | $13.20M(+3.9%) |
| Jan 1991 | - | $12.70M(-5.9%) |
| Oct 1990 | - | $13.50M(-11.2%) |
| Jul 1990 | - | $15.20M(-2.6%) |
| Apr 1990 | $15.60M(+18.2%) | $15.60M(+32.2%) |
| Jan 1990 | - | $11.80M(-10.6%) |
| Apr 1989 | $13.20M(+1.5%) | $13.20M(+1.5%) |
| Apr 1988 | $13.00M(-11.0%) | $13.00M(-11.0%) |
| Apr 1987 | $14.60M(+356.3%) | $14.60M(+356.3%) |
| Apr 1986 | $3.20M | $3.20M |
FAQ
- What is Celldex Therapeutics annual total assets?
- What is the all time high annual total assets for Celldex Therapeutics?
- What is Celldex Therapeutics annual total assets year-on-year change?
- What is Celldex Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly total assets year-on-year change?
What is Celldex Therapeutics annual total assets?
The current annual total assets of CLDX is $792.34M
What is the all time high annual total assets for Celldex Therapeutics?
Celldex Therapeutics all-time high annual total assets is $792.34M
What is Celldex Therapeutics annual total assets year-on-year change?
Over the past year, CLDX annual total assets has changed by +$326.71M (+70.17%)
What is Celldex Therapeutics quarterly total assets?
The current quarterly total assets of CLDX is $739.47M
What is the all time high quarterly total assets for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly total assets is $868.85M
What is Celldex Therapeutics quarterly total assets year-on-year change?
Over the past year, CLDX quarterly total assets has changed by -$129.38M (-14.89%)